ストックスクリーナーアプリを入手
1.46
3.55%
0.05
アフターアワーズ：
1.40
-0.06
-4.11%
前日終値:
$1.41
開ける：
$1.39
24時間の取引高:
114.07K
Relative Volume:
0.18
時価総額：
$131.85M
収益：
-
当期純損益:
$1.60M
株価収益率:
48.67
EPS:
0.03
ネットキャッシュフロー:
$-62.91M
1週間 パフォーマンス:
-4.58%
1か月 パフォーマンス:
-23.96%
6か月 パフォーマンス:
-24.35%
1年 パフォーマンス:
-37.61%
1日の値動き範囲:
$1.384
$1.46
1週間の範囲:
$1.384
$1.555
52週間の値動き範囲:
$1.35
$2.66
Compugen Ltd Stock (CGEN) Company Profile
CGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.46 | 131.85M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-13 | 開始されました | Oppenheimer | Outperform |
| 2022-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-26 | 再開されました | JMP Securities | Mkt Outperform |
| 2020-05-13 | 開始されました | Stifel | Buy |
| 2020-05-07 | 開始されました | SVB Leerink | Outperform |
| 2020-04-22 | 開始されました | ROTH Capital | Buy |
| 2020-03-24 | 開始されました | SunTrust | Buy |
| 2020-01-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-03-29 | 開始されました | Oppenheimer | Outperform |
| 2016-02-01 | 再開されました | Oppenheimer | Outperform |
| 2015-10-15 | 開始されました | FBR Capital | Outperform |
| 2015-04-23 | 再開されました | Jefferies | Buy |
| 2015-04-21 | 開始されました | Oppenheimer | Outperform |
| 2014-02-07 | 開始されました | MLV & Co | Buy |
| 2009-12-28 | 繰り返されました | Cantor Fitzgerald | Buy |
| 2009-07-29 | 開始されました | Cantor Fitzgerald | Buy |
すべてを表示
Compugen Ltd (CGEN) 最新ニュース
Compugen at AI Drug Discovery Conference: Strategic Partnerships Drive Progress - Investing.com
Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan
Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts - MSN
Compugen Ltd. (NASDAQ:CGEN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - Defense World
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter
Compugen at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com South Africa
Oppenheimer & Co. Inc. Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World
Earnings call transcript: Compugen Q4 2024 reveals revenue decline By Investing.com - Investing.com Australia
Compugen Ltd. to Host Earnings Call - ACCESS Newswire
Compugen (NASDAQ:CGEN) Rating Lowered to Hold at StockNews.com - Defense World
Rodman & Renshaw maintains $4 price target on Compugen stock By Investing.com - Investing.com Australia
Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript - Insider Monkey
Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com
Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability - TipRanks
Earnings call transcript: Compugen Q4 2024 reveals revenue decline - Investing.com India
Rodman & Renshaw maintains $4 price target on Compugen stock - Investing.com India
Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Compugen: Q4 Earnings Snapshot - CTPost
Compugen earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa
Compugen Reports 2024 Financial Results and Clinical Progress - TipRanks
Compugen: Q4 Earnings Snapshot -March 04, 2025 at 07:23 am EST - Marketscreener.com
Compugen Reports Fourth Quarter and Full Year 2024 Results -March 04, 2025 at 07:13 am EST - Marketscreener.com
Compugen reports Q4 EPS (7c) vs. 11c last year - TipRanks
Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Loss $-0.07 Per Share -March 04, 2025 at 07:08 am EST - Marketscreener.com
Earnings Flash (CW9) COMPUGEN LTD. Posts Q4 Revenue $1.5M - Marketscreener.com
Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Revenue $1.5M -March 04, 2025 at 07:09 am EST - Marketscreener.com
How Compugen's Cancer Immunotherapy Pipeline Is Advancing While Extending Cash Runway to 2027 - StockTitan
Cancer Immunotherapy Pioneer Compugen to Share Insights at Major Healthcare Conference - StockTitan
Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference - Yahoo Finance
Compugen (CGEN) Projected to Post Quarterly Earnings on Tuesday - Defense World
Compugen Ltd expected to post earnings of 7 cents a shareEarnings Preview - TradingView
Compugen (CGEN) Expected to Announce Earnings on Tuesday - MarketBeat
Improved Revenues Required Before Compugen Ltd. (NASDAQ:CGEN) Shares Find Their Feet - Simply Wall St
How Compugen's AI Platform Partnership Could Revolutionize Cancer Immunotherapy Discovery - StockTitan
Compugen Ltd. Enhances its AI/ML Predictive Computational Discovery Platform, Unigen?? with Ultima Genomics' Single Cell Genomics Sequencing Technology - Marketscreener.com
Compugen Ltd. Sets Date for Q4 2024 Financial Results Announcement - TipRanks
Earnings Alert: Compugen Sets Date for Critical Year-End Financial Report & Strategic Update - StockTitan
Compugen: Immuno-Oncology Innovator Poised For A Comeback (NASDAQ:CGEN) - Seeking Alpha
Compugen (NASDAQ:CGEN) Shares Cross Above 200-Day Moving Average – Time to Sell? - Defense World
Compugen Announces Significant Share Price Increase - TipRanks
Compugen Updates Filing Structure with Bristol Myers Squibb - TipRanks
Computational Biology Market to Generate $9.52 Billion in Revenues in 2025; Forecast to Reach $22.47 Billion by 2029Analysis of the Key Drivers, Top Segments, Regional Shifts, Leading Players & More - Yahoo Finance
Financial Comparison: Compugen (NASDAQ:CGEN) & Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World
CGEN’s Q2 earnings predictions: What the experts say - US Post News
Compugen Ltd (NASDAQ: CGEN) Has Decreased By 14.22 Percent This Year. Is It A Better Buy Than Others? - Marketing Sentinel
JPMorgan Chase & Co. Has $122,000 Stock Holdings in Compugen Ltd. (NASDAQ:CGEN) - MarketBeat
Views of Wall Street’s Leading Experts on Compugen Ltd - SETE News
The Psychology of Compugen Ltd Inc. (CGEN) Price Performance: Understanding Market Sentiment - The InvestChronicle
Insider’s View: Deciphering Compugen Ltd (CGEN)’s Financial Health Through Ratios - The Dwinnex
Compugen Ltd (CGEN) 財務データ
収益
当期純利益
現金流量
EPS
2.00%
大文字化:
|
ボリューム (24 時間):